Core C: Clinical Resarch Laboratory
核心C:临床研究实验室
基本信息
- 批准号:9762813
- 负责人:
- 金额:$ 75.25万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:
- 资助国家:美国
- 起止时间:至
- 项目状态:未结题
- 来源:
- 关键词:AccountabilityAcuteAntibodiesAntigensBiochemistryBiological AssayBiological ProcessBlood specimenClinicalClinical ResearchComplexCountryCryopreservationCulicidaeDataDengueDengue InfectionDengue VaccineDengue VirusDiagnosisDiagnosticDiagnostics ResearchDoctor of PhilosophyEnsureEnzyme ImmunoassayEquipment and supply inventoriesExperimental DesignsFamilyFlavivirusFlavivirus InfectionsFlow CytometryGoalsHematologyHuman ResourcesImmune responseImmunityImmunologicsInformation TechnologyLaboratoriesLaboratory ResearchLaboratory StudyLogisticsMediator of activation proteinMicrobiologyMolecularNeutralization TestsOutcomePathogenesisPeripheral Blood Mononuclear CellPhilippinesPlasmaPreventionProceduresProcessProspective cohortProteomicsProtocols documentationPublishingRNAResearchResearch PersonnelReverse Transcriptase Polymerase Chain ReactionSamplingSecureSerodiagnosesSerologicalServicesShippingSiteSoutheastern AsiaSpecimenSpecimen HandlingStandardizationStructureStudy SubjectSystemTemperatureTestingThailandViral Load resultepidemiology studylaboratory experimentmolecular diagnosticsoperationprogramsrapid diagnosistraining projecttransmission processvectorviral RNAviral transmissionvirology
项目摘要
Project Summary/Abstract
This Program Project takes a comprehensive approach to investigating dengue virus (DENV)
transmission within a family setting (Project 1), defining the early immune response to DENV and its correlations
to outcomes (Project 2), and investigating immune responses in DENV vaccine recipients (Project 3). These
projects include studies with distinct experimental designs with two large prospective cohorts conducted in two
countries (Thailand and the Philippines). This complex and integrative research effort will be supported by a
laboratory core (Core C) which will provide high quality laboratory support for specimen processing, management,
and routine clinical and dengue diagnostic laboratory testing. The Clinical Research Laboratory Core (Core C)
consists of 3 facilities: a) AFRIMS-Virology laboratory in Bangkok, Thailand (Core C-BKK), b) AFRIMS-Virology
laboratory in Kamphaeng Phet (Core C-KPP), Thailand, and c) AFRIMS-Virology laboratory in Cebu, the
Philippines (Core C-Cebu). Core C-BKK has been conducting research in Southeast Asia and nearby regions
for over 50 years and has served as a reference laboratory for flavivirus diagnosis; it will serve as the
administrative and logistics center for laboratory activities and will be the main laboratory for serologic diagnosis
and for study-specific specialized tests. Core C-KPP will be the main facility for specimen processing for Projects
1 and 2; it will also serve as a molecular diagnostic laboratory and perform research laboratory testing including
assessment of viral burden and analysis of immune responses by flow cytometry and antigen and antibody
assays. Core C-Cebu is currently the main specimen processing facility for samples collected from dengue
vaccine study subjects in Project 3. The Core Laboratory will be the center for specimen storage, inventory, and
distribution. The Core Laboratory has a secure and accountable inventory system that has facilitated sample
distribution to diagnostic and research laboratories. Since the beginning of the Program Project, the Core
Laboratory has processed and managed specimens including plasma/serum, cryopreserved PBMC, and RNA
from PBMC. These samples have been used for functional antibody assays, assays for biological mediators,
and molecular and proteomic analyses that have been published and contributed to current understanding on
many aspects of dengue. Study-specific quality management plans have been established and the laboratory’s
operation is audited quarterly for specimen chain custody, specimen handling, and sample accountability.
项目总结/文摘
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Anon Srikiatkhachorn其他文献
Anon Srikiatkhachorn的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Anon Srikiatkhachorn', 18)}}的其他基金
REGULATORY ROLE OF VIRUS SPECIFIC CD8ANDT LYMPHOCYTES
病毒特异性 CD8ANDT 淋巴细胞的调节作用
- 批准号:
6171038 - 财政年份:1998
- 资助金额:
$ 75.25万 - 项目类别:
REGULATION OF CD4+ T CELL DIFFERENTITION BY CD8+ T CELLS
CD8 T 细胞对 CD4 T 细胞分化的调节
- 批准号:
2452245 - 财政年份:1998
- 资助金额:
$ 75.25万 - 项目类别:
REGULATORY ROLE OF VIRUS SPECIFIC CD8ANDT LYMPHOCYTES
病毒特异性 CD8ANDT 淋巴细胞的调节作用
- 批准号:
2887964 - 财政年份:1998
- 资助金额:
$ 75.25万 - 项目类别:
REGULATORY ROLE OF VIRUS SPECIFIC CD8ANDT LYMPHOCYTES
病毒特异性 CD8ANDT 淋巴细胞的调节作用
- 批准号:
2866837 - 财政年份:1998
- 资助金额:
$ 75.25万 - 项目类别:
REGULATORY ROLE OF VIRUS SPECIFIC CD8ANDT LYMPHOCYTES
病毒特异性 CD8ANDT 淋巴细胞的调节作用
- 批准号:
6374134 - 财政年份:1998
- 资助金额:
$ 75.25万 - 项目类别:
相似海外基金
Neutralizing Antibodies in Acute and Persistent Epstein-Barr Virus Infection
急性和持续性 Epstein-Barr 病毒感染中的中和抗体
- 批准号:
8965501 - 财政年份:2014
- 资助金额:
$ 75.25万 - 项目类别:
Neutralizing Antibodies in Acute and Persistent Epstein-Barr Virus Infection
急性和持续性 Epstein-Barr 病毒感染中的中和抗体
- 批准号:
9182818 - 财政年份:2014
- 资助金额:
$ 75.25万 - 项目类别:
Neutralizing Antibodies in Acute and Persistent Epstein-Barr Virus Infection
急性和持续性 Epstein-Barr 病毒感染中的中和抗体
- 批准号:
8854409 - 财政年份:2014
- 资助金额:
$ 75.25万 - 项目类别:
Development ofTherapeutic Antibodies Targeting Human Acute Myeloid Leukemia Stem Cells
针对人急性髓性白血病干细胞的治疗性抗体的开发
- 批准号:
G1000729/1 - 财政年份:2010
- 资助金额:
$ 75.25万 - 项目类别:
Research Grant
The relationship between anti-donor antibodies and acute rejection in lung transplantation
抗供体抗体与肺移植急性排斥反应的关系
- 批准号:
12671311 - 财政年份:2000
- 资助金额:
$ 75.25万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
NON-NEUTRALIZING ANTIBODIES IN ACUTE PRIMARY HIV INFECTION
急性原发性 HIV 感染中的非中和抗体
- 批准号:
6347230 - 财政年份:2000
- 资助金额:
$ 75.25万 - 项目类别:
NON-NEUTRALIZING ANTIBODIES IN ACUTE PRIMARY HIV INFECTION
急性原发性 HIV 感染中的非中和抗体
- 批准号:
6201348 - 财政年份:1999
- 资助金额:
$ 75.25万 - 项目类别:
NON-NEUTRALIZING ANTIBODIES IN ACUTE PRIMARY HIV INFECTION
急性原发性 HIV 感染中的非中和抗体
- 批准号:
6100126 - 财政年份:1998
- 资助金额:
$ 75.25万 - 项目类别:
NON-NEUTRALIZING ANTIBODIES IN ACUTE PRIMARY HIV INFECTION
急性原发性 HIV 感染中的非中和抗体
- 批准号:
6235545 - 财政年份:1997
- 资助金额:
$ 75.25万 - 项目类别:
HUMAN AND MURINE HYBRIDOMA ANTIBODIES IN ACUTE LEUKEMIAS
急性白血病中的人和鼠杂交瘤抗体
- 批准号:
3172843 - 财政年份:1983
- 资助金额:
$ 75.25万 - 项目类别: